Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the mfn-opts domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/brownpelican/wp-includes/functions.php on line 6131
Abortion Drug Makers Admit They Care About Money, Not Women, by Jordan Boyd – Brown Pelican Society of Lousiana

Abortion Drug Makers Admit They Care About Money, Not Women, by Jordan Boyd

U.S. Birth Rate Hits Record Lows as Liberals Reject Marriage and Family, by Dan Hart

May 6, 2026

The World Isn’t Your Friend, by Casey Chalk

May 6, 2026

Polina Tankilevitch. Pexels. Woman taking pill.

By Jordan Boyd, The Federalist, May 06, 2026

is an award-winning staff writer at The Federalist and producer of “The Federalist Radio Hour.” Her work has also been featured in The Daily Wire, Fox News, and RealClearPolitics. Jordan graduated from Baylor University where she majored in political science and minored in journalism. Follow her on X @jordanboydtx.

The court ruled mifepristone makers’ ‘potential financial losses pale beside … interest in not exposing women to unsafe medical procedures.’

The company responsible for manufacturing the most popular abortion pill on the market are more concerned about its profits than the harm its drugs are inflicting on women and babies.

The confession from mifepristone maker Danco Laboratories came in its defense against Louisiana’s landmark lawsuit targeting the U.S. Food and Drug Administration’s “mail-order abortion scheme.” The 5th Circuit Court of Appeals unanimously granted Louisiana’s request for a stay, effectively pausing the FDA’s mail-order abortion drug permissions. While the U.S. Supreme Court temporarily halted the 5th Circuit’s block just two days until both parties can brief the court, the case is considered ongoing. …

Continue reading >>>>>>>

Abortion Drug Makers Admit They Care About Money, Not Women, by Jordan Boyd

U.S. Birth Rate Hits Record Lows as Liberals Reject Marriage and Family, by Dan Hart

The World Isn’t Your Friend, by Casey Chalk

By Jordan Boyd, The Federalist, May 06, 2026

The court ruled mifepristone makers’ ‘potential financial losses pale beside … interest in not exposing women to unsafe medical procedures.’

The company responsible for manufacturing the most popular abortion pill on the market are more concerned about its profits than the harm its drugs are inflicting on women and babies.

Related posts

Diane Montagna’s Substack: Has the Vatican’s Synod Office Become Fr. James Martin’s PR Arm?

Abortion Haven of New Mexico Eliminates All Reporting of Abortion Data, by Angeline Tan

The World Isn’t Your Friend, by Casey Chalk